Laurent Fischer, Director at Mirum Pharmaceuticals, Inc. (MIRM), bought 2,100 shares at $9.47 ($20K) on 2019-09-16, disclosed to the SEC on 2019-09-18.
Open-market purchase of $20k MIRM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.47 | 452 | $4K | 21.7% |
| 2 | $9.37 | 1,648 | $15K | 78.3% |
| Total | $9.39 avg | 2,100 | $20K | 100% |
| Filing → |
| ADVM | SELL | 2023-03-17 | $32K | — | Filing → |
| ADVM | SELL | 2022-09-21 | $44K | — | Filing → |
| ADVM | BUY | 2022-04-22 | $28K | — | Filing → |